| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy. | JAMA Neurol | 2013 | 1.01 |
| 2 | Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2'-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN. | Biochem Pharmacol | 2009 | 0.95 |
| 3 | Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice. | Mol Ther Nucleic Acids | 2012 | 0.80 |